The presence of white tofu-like discharge from the vulva in women is considered the presence of vaginal inflammation, usually pseudomonal vaginosis, a common vulvovaginal inflammatory disease caused by Pseudomonas aeruginosa. It usually requires treatment for the predisposing factors, timely discontinuation of broad-spectrum antibiotics, estrogen and other drugs, and active treatment of diabetes mellitus in the presence of diabetes mellitus. In addition, treatment is needed for different cases of inflammatory episodes: i. Simple vulvovaginal pseudomycosis: often treated with azole antifungal drugs, topical clotrimazole preparations, miconazole preparations, mycobacterium preparations, and other drugs. For unmarried girls and those who are not suitable for local medication, oral medication can be used, commonly used drug is fluconazole. Second, complex vulvovaginal pseudomycosis: 1, severe vulvovaginal pseudomycosis: extend a course of treatment based on the treatment of simple vulvovaginal pseudomycosis; 2, recurrent vulvovaginal pseudomycosis: four or more episodes of symptomatic and mycologically confirmed vulvovaginal pseudomycosis within one year is called recurrent vulvovaginal pseudomycosis. Treatment focuses on actively seeking and removing the causative agent and preventing recurrence. The doctor will select medications based on fungal cultures and drug sensitivity tests and intensify treatment until the fungus is cured, and will give six months of consolidation therapy. The intensive treatment regimen means extending the treatment of simple vulvovaginal pseudomycosis by 1-2 courses of treatment. Patients should also have a fungal culture of vaginal secretions before treatment along with a drug sensitivity test, regular review during treatment to monitor the efficacy, and pay attention to the side effects of the drug. Once side effects such as abnormal liver function occur, stop the drug immediately and replace it with other drugs when the side effects disappear; 3. Pseudomycosis vulvovaginalis during pregnancy: local medication is the mainstay, and a long course of treatment in small doses is preferred, and oral azole antifungal drugs are prohibited. Patients are advised to follow up regularly for 7-14 days at the end of treatment for follow-up review. If symptoms persist or recur after treatment, a fungal culture may be performed along with a drug sensitivity test. In addition, for sexual partners with glans inflammation, pseudomonal yeast examination and treatment is required to prevent repeated infection in girls.